FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3100962608> ?p ?o ?g. }

• W3100962608 abstract "Background: This study aimed to evaluate whether the high frequency of reported statin adverse effects (AEs) may be associated with the nocebo effect. We compared nocebo-related subjective AEs with objective AEs and investigated factors potentially associated with the nocebo effect. Methods: A retrospective cohort study was conducted using the Food and Drug Administration Adverse Event Reporting System between January 2010 and December 2019 for statins, including, atorvastatin, lovastatin, pravastatin, rosuvastatin, and simvastatin. Subjective AEs included fatigue, subjective muscular, and nervous system AEs. Objective AEs were defined as hepatic and objective muscular AEs. We compared the number of subjective and objective AEs using the Mann-Whitney U test and examined trends in the frequency of subjective versus objective reports over time using linear regression with interaction terms. We evaluated the association between AEs and gender and country using linear regression. Quantitative detection of signals was estimated using proportional reporting ratio and reporting odds ratio for simvastatin. Results: Of 2 994 487 overall AE reports, more subjective than objective AEs were reported per quarter (mean±SD: 4777±1375.45 versus 999±276.95; P <0.0001), and over time during the study period ( P <0.001). Women reported more subjective AEs than men per quarter (fatigue: 86.98 more per quarter, P =0.035; subjective muscular AE: 417.95, P <0.0001; nervous system AE: 273.60, P <0.0001), but fewer objective muscular AEs (−125.23 per quarter, P <0.0001). More subjective AEs and fewer objective AEs were reported per quarter in the United States relative to other countries. Simvastatin-associated reports showed signals for higher objective muscular AEs relative to all other statins (reporting odds ratio, 1.53 [95% CI, 1.49–1.58]). Conclusions: This study found that significantly more subjective than objective AEs are reported for statins. Subjective statin AEs, potentially related to the nocebo effect are reported more often by women than by men, and in the United States than in other countries." @default.
• W3100962608 created "2020-11-23" @default.
• W3100962608 creator A5004859111 @default.
• W3100962608 creator A5026810135 @default.
• W3100962608 creator A5031708501 @default.
• W3100962608 date "2021-01-01" @default.
• W3100962608 modified "2023-10-14" @default.
• W3100962608 title "Examining the Nocebo Effect of Statins Through Statin Adverse Events Reported in the Food and Drug Administration Adverse Event Reporting System" @default.
• W3100962608 cites W1523152575 @default.
• W3100962608 cites W1974005985 @default.
• W3100962608 cites W1995674909 @default.
• W3100962608 cites W1998569580 @default.
• W3100962608 cites W1998939122 @default.
• W3100962608 cites W2006533450 @default.
• W3100962608 cites W2010033213 @default.
• W3100962608 cites W2030711540 @default.
• W3100962608 cites W2051160165 @default.
• W3100962608 cites W2062803352 @default.
• W3100962608 cites W2064716383 @default.
• W3100962608 cites W2070268037 @default.
• W3100962608 cites W2082270415 @default.
• W3100962608 cites W2085752173 @default.
• W3100962608 cites W2100554124 @default.
• W3100962608 cites W2106734896 @default.
• W3100962608 cites W2113514677 @default.
• W3100962608 cites W2134159541 @default.
• W3100962608 cites W2156560844 @default.
• W3100962608 cites W2160812379 @default.
• W3100962608 cites W2164089346 @default.
• W3100962608 cites W2167418359 @default.
• W3100962608 cites W2218843182 @default.
• W3100962608 cites W2314193179 @default.
• W3100962608 cites W2344423704 @default.
• W3100962608 cites W2388471644 @default.
• W3100962608 cites W2418078838 @default.
• W3100962608 cites W2491236613 @default.
• W3100962608 cites W2505379829 @default.
• W3100962608 cites W2525232210 @default.
• W3100962608 cites W2610498431 @default.
• W3100962608 cites W2739634460 @default.
• W3100962608 cites W2801836773 @default.
• W3100962608 cites W2892517513 @default.
• W3100962608 cites W2898046550 @default.
• W3100962608 cites W2900034165 @default.
• W3100962608 cites W2902007237 @default.
• W3100962608 cites W2905331745 @default.
• W3100962608 cites W2968097947 @default.
• W3100962608 cites W2971327740 @default.
• W3100962608 cites W2999915237 @default.
• W3100962608 cites W3183857127 @default.
• W3100962608 cites W4236673002 @default.
• W3100962608 doi "https://doi.org/10.1161/circoutcomes.120.007480" @default.
• W3100962608 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33161769" @default.
• W3100962608 hasPublicationYear "2021" @default.
• W3100962608 type Work @default.
• W3100962608 sameAs 3100962608 @default.
• W3100962608 citedByCount "14" @default.
• W3100962608 countsByYear W31009626082021 @default.
• W3100962608 countsByYear W31009626082022 @default.
• W3100962608 countsByYear W31009626082023 @default.
• W3100962608 crossrefType "journal-article" @default.
• W3100962608 hasAuthorship W3100962608A5004859111 @default.
• W3100962608 hasAuthorship W3100962608A5026810135 @default.
• W3100962608 hasAuthorship W3100962608A5031708501 @default.
• W3100962608 hasBestOaLocation W31009626081 @default.
• W3100962608 hasConcept C126322002 @default.
• W3100962608 hasConcept C142724271 @default.
• W3100962608 hasConcept C156957248 @default.
• W3100962608 hasConcept C197934379 @default.
• W3100962608 hasConcept C204787440 @default.
• W3100962608 hasConcept C27081682 @default.
• W3100962608 hasConcept C2776329913 @default.
• W3100962608 hasConcept C2776839432 @default.
• W3100962608 hasConcept C2777105317 @default.
• W3100962608 hasConcept C2777482532 @default.
• W3100962608 hasConcept C2778163477 @default.
• W3100962608 hasConcept C2778360308 @default.
• W3100962608 hasConcept C2779519902 @default.
• W3100962608 hasConcept C2780499067 @default.
• W3100962608 hasConcept C71924100 @default.
• W3100962608 hasConceptScore W3100962608C126322002 @default.
• W3100962608 hasConceptScore W3100962608C142724271 @default.
• W3100962608 hasConceptScore W3100962608C156957248 @default.
• W3100962608 hasConceptScore W3100962608C197934379 @default.
• W3100962608 hasConceptScore W3100962608C204787440 @default.
• W3100962608 hasConceptScore W3100962608C27081682 @default.
• W3100962608 hasConceptScore W3100962608C2776329913 @default.
• W3100962608 hasConceptScore W3100962608C2776839432 @default.
• W3100962608 hasConceptScore W3100962608C2777105317 @default.
• W3100962608 hasConceptScore W3100962608C2777482532 @default.
• W3100962608 hasConceptScore W3100962608C2778163477 @default.
• W3100962608 hasConceptScore W3100962608C2778360308 @default.
• W3100962608 hasConceptScore W3100962608C2779519902 @default.
• W3100962608 hasConceptScore W3100962608C2780499067 @default.
• W3100962608 hasConceptScore W3100962608C71924100 @default.
• W3100962608 hasIssue "1" @default.
• W3100962608 hasLocation W31009626081 @default.
• W3100962608 hasOpenAccess W3100962608 @default.
• W3100962608 hasPrimaryLocation W31009626081 @default.
• W3100962608 hasRelatedWork W1971567197 @default.

• next